ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 77 filers reported holding ADAGIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,017 | -15.1% | 22,951 | -47.6% | 0.00% | – |
| Q2 2023 | $45,950 | -53.5% | 43,762 | -46.8% | 0.00% | – |
| Q1 2023 | $98,780 | +1.8% | 82,317 | +27.3% | 0.00% | – |
| Q4 2022 | $97,024 | -77.9% | 64,682 | -54.0% | 0.00% | – |
| Q3 2022 | $440,000 | -67.5% | 140,464 | -66.0% | 0.00% | – |
| Q2 2022 | $1,353,000 | +673.1% | 412,564 | +976.5% | 0.00% | – |
| Q1 2022 | $175,000 | +4.8% | 38,323 | +66.7% | 0.00% | – |
| Q4 2021 | $167,000 | – | 22,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $13,872,375 | 13.22% |
| Alphabet Inc. | 5,680,785 | $8,521,178 | 0.50% |
| 683 Capital Management, LLC | 3,000,000 | $4,500,001 | 0.38% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $2,906 | 0.32% |
| Slate Path Capital LP | 3,735,000 | $5,602,500 | 0.30% |
| Newtyn Management, LLC | 900,000 | $1,350,000 | 0.28% |
| Orbimed Advisors | 5,270,400 | $7,905,600 | 0.15% |
| Oasis Management Co Ltd. | 348,432 | $522,648 | 0.10% |
| Redmile Group, LLC | 1,440,725 | $2,161,088 | 0.09% |
| Anson Funds Management LP | 154,156 | $231,234 | 0.04% |